VIGL - vigilneuro.com Operating income before deduction of amortization
Vigil Neuroscience restores the brain's neuroimmunity using patent-protected formulas to generate long-term revenue. EBITDA_Co monitoring demonstrates a steady cash inflow, where the value of reflects the metric's balance. The success of Vigil Neuroscience (VIGL) is based on regulatory approval of its therapies and the availability of capital. The development of ideas occurs organically through attracting investments from specialized funds for specific R&D stages.
Vigil Neuroscience, Inc. (VIGL) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization statistics:
- balance sheet equity data:
- debt level and financial liquidity data:
Debt to Equity Ratio Vigil Neuroscience|VIGL - Long-Term Debt to Capital|Current Liabilities to Capital Vigil Neuroscience Inc.|VIGL - Company Total Debt|Debts to Book Capitalization Vigil Neuroscience|VIGL - Company Long-Term Debt|Company Short-Term Loans and Borrowings Vigil Neuroscience|Immediate Liquidity vigilneuro.com
- net income and valuation multiples indicators:
VIGL - Company Net Income|Company Profit Forecast Vigil Neuroscience|VIGL - P/E Multiple|Projected Price to Earnings Vigil Neuroscience Inc.|VIGL - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Vigil Neuroscience|VIGL - Operating profit EBITDA|Net earnings per one share for the last twelve months Vigil Neuroscience|VIGL - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months vigilneuro.com|VIGL - Earnings growth in current year|Expected earnings per share growth for next year Vigil Neuroscience
Fundamental company valuation:VIGL (Vigil Neuroscience)
Vigil Neuroscience (VIGL) is in the early stages of clinical development, where a lack of revenue and rising R&D costs are blocking operating leverage. This EBITDA reflects the actual cash flow from core operations, allowing for an assessment of spending trends relative to historical periods to avoid erroneous growth extrapolation and overpaying for the asset.
Competitors of Vigil Neuroscience (VIGL)
Operating profit before depreciation charges Biogen Idec|Neurocrine Biosciences - Operating profit EBITDA|Operating income before deduction of amortization regencellbioscience.com RGC|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|ACAD (ACADIA Pharma) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization XENE|VKTX: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Supernus Pharmaceuticals (SUPN)|catalystpharma.com - Operating profit before amortization|Operating profit EBITDA DNLI (Denali Therapeutics Inc.)|Harmony Biosciences Inc (HRMY) - Profit before interest, taxes and amortization|BHVN: Operating profit before deduction of amortization|AMLX - Operating profit EBITDA|Trevi Therapeutics (TRVI) - Profit before payment of interest, taxes and amortization|praxismedicines.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Anavex Life Sciences Corp.|Profit before interest, taxes and amortization CeriBell Inc CBLL|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|Operating income before deduction of amortization alector.com|Operating profit EBITDA ANNX (Annexon, Inc.)|OMER - Operating profit before deduction of amortization|Neurogene - Operating profit EBITDA|Operating income before deduction of amortization AC Immune S.A. ACIU|VYGR: Operating profit EBITDA|Profit before interest, taxes and amortization Neumora Corp (NMRA)|Profit before payment of interest, taxes and amortization Scilex Holding Company|Operating profit before amortization TVGN (tevogen.com)|Operating profit EBITDA ACOG|Operating profit before deduction of amortization Cognition Therapeutics Inc. CGTX|Operating profit EBITDA IKT (Inhibikase)|Cassava Pharma (SAVA) - Profit before interest, taxes and amortization|ASRT: Operating profit before deduction of amortization|COYA: Profit before payment of interest, taxes and amortization|VTGN: Operating profit EBITDA|OVID - Operating income before deduction of amortization|ABOS (Acumen Pharma) - Operating profit EBITDA|CRVO - Operating profit before depreciation charges|Profit before payment of interest, taxes and amortization Alterity Therapeutics (ATHE)|Profit before payment of interest, taxes and amortization CLNN (clene.com)|Profit before payment of interest, taxes and amortization PepGen PEPG|JUNS: Operating profit before amortization|Relmada - Operating profit EBITDA|Profit before interest, taxes and amortization Annovis Bio Corporation|GRCE (gracetx.com) - Operating profit before deduction of amortization|fireflyneuro.com (AIFF) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization ANEW Medical|NRSN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Reviva Pharmaceuticals Holdings (RVPH)|MTVA - Profit before interest, taxes and amortization|NeurAxis, Inc. - Operating profit before deduction of amortization|Helius Medical Technologies, Inc. - Profit before payment of interest, taxes and amortization|Passage Bio Corp - Operating profit EBITDA|Operating income before deduction of amortization Neuphoria Therapeutics Inc. NEUP|NERV: Operating profit EBITDA|Operating profit before depreciation charges Athira Pharma Corp ATHA|ADXN (Addex Therapeutics) - Operating profit EBITDA|Alzamend (ALZN) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cyclerion Therapeutics (CYCN)|Profit before payment of interest, taxes and amortization PTIX (protagenic.com)|Pasithea Therapeutics Corp. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization CRGT|ATXI - Profit before payment of interest, taxes and amortization|BCLI (brainstorm-cell.com) - Operating profit before amortization|CARA: Operating profit EBITDA|Profit before interest, taxes and amortization Chromocell Therapeutics Corp (CHRO)|Operating profit before deduction of amortization ELYM|Operating profit EBITDA Intra-Cellular|Profit before payment of interest, taxes and amortization Longboard Pharmaceuticals (LBPH)|MRNS (marinuspharma.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization NKGen Biotech NKGN|NeuroBo Pharmaceuticals Inc (NRBO) - Profit before interest, taxes and amortization|SAGE - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Synaptogenix, Inc SNPX|TRVN: Operating profit EBITDA|Operating profit before deduction of amortization anewmeds.com|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
